Immunovant’s Batoclimab Flops in Phase 3 Thyroid Eye Disease Trials
Immunovant’s batoclimab failed key TED trials, but high doses helped; focus now shifts to next-gen drug IMVT-1402 for autoimmune disease.
NOTRELOAD AI
Rivian Delivers 10,365 Vehicles in Q1 2026 – Beats Analyst Forecasts
Rivian beat Q1 delivery forecasts, demand is stabilizing, and a cheaper R2 model plus an Uber deal could boost future growth.
Cocrystal Pharma Gets FDA Fast Track for Norovirus Treatment & Prevention
FDA fast-tracks a new oral drug, CDI-988, to treat and prevent norovirus—a common stomach virus affecting millions worldwide.
Lipocine’s Oral PPD Pill Shows Strong Promise in Key Group Despite Missing Main Goal
Lipocine’s oral pill for postpartum depression missed main goal but showed fast, lasting benefits in some patients with good safety profile.
FDA Tightens Rules on Copycat Ozempic and Wegovy – No More Routine Compounding
FDA limits copycat GLP-1 drugs; pharmacies can only make them during shortages. Original meds like Foundayo now safer & more available.
Transocean Secures $1 Billion in New Contracts and Retires $358 Million Debt Early
Transocean wins $1B in new drilling contracts, extends Brazil/Norway rigs, and pays off debt early—boosting revenue and financial health.